POSITIVE AND NEGATIVE SELECTION EVENTS DURING B-LYMPHOPOIESIS

被引:161
|
作者
MELCHERS, F
ROLINK, A
GRAWUNDER, U
WINKLER, TH
KARASUYAMA, H
GHIA, P
ANDERSSON, J
机构
[1] Basel Institute for Immunology, CH-4005 Basel
关键词
D O I
10.1016/0952-7915(95)80006-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Early in B-cell development, large numbers of cells have to be generated, each of which expresses only one type of B-cell receptor (i.e. Ig) on its surface. This is achieved by the surface expression of a pre-B cell receptor containing a mu heavy chain/surrogate light chain which differentially provides signals for two responses of precursor B cells at this stage of development. On the one hand, it signals inhibition of further rearrangements of variable heavy chain to diverse-joining heavy chain loci to achieve allelic exclusion at the heavy-chain locus. On the other hand, it signals proliferative expansion by factors between 20 and 100. Later in B-cell development, tolerance to autoantigens must be established and maintained. Tolerance is achieved by developmental arrest and induction of secondary light-chain gene rearrangements in those IgM+ immature B cells that are reactive to autoantigens presented in the primary B-cell generating organs. Even later in development, when mature surface (s)IgM+/sIgD+ B cells encounter autoantigens presented to them in the periphery, either deletion or anergy of the autoantigen-reactive cells occurs. Anergic cells have a sig-dependent, sIg-proximal defect in signaling and are short-lived. Anergy can be broken in vitro by polyclonal activation via ligation of CD40 in the presence of IL-4. A small part of the remaining immature B cells not reactive to autoantigens are selected to become mature, antigen-reactive sIgM+/sIgD+ B cells. Molecules which might guide such positive selection of B cells still remain to be identified.
引用
下载
收藏
页码:214 / 227
页数:14
相关论文
共 50 条
  • [21] Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling
    Amanda E. Au
    Marion Lebois
    Starling A. Sim
    Ping Cannon
    Jason Corbin
    Pradnya Gangatirkar
    Craig D. Hyland
    Diane Moujalled
    Angelika Rutgersson
    Fatme Yassinson
    Benjamin T. Kile
    Kylie D. Mason
    Ashley P. Ng
    Warren S. Alexander
    Emma C. Josefsson
    Scientific Reports, 7
  • [22] VCAM-1 expression in B-lymphopoiesis and leukemia
    Young, FM
    Felgar, RE
    Eyssallenne, AP
    Bottaro, A
    Bushnell, TP
    BLOOD, 2004, 104 (11) : 886A - 887A
  • [23] CYTOKINE REGULATION OF EARLY B-LYMPHOPOIESIS ASSESSED IN CULTURE
    HIRAYAMA, F
    OGAWA, M
    BLOOD CELLS, 1994, 20 (2-3): : 341 - 347
  • [24] ESTABLISHMENT OF AN IN-VITRO MODEL FOR HUMAN B-LYMPHOPOIESIS
    NAMIKAWA, R
    MUENCH, MO
    RENNICK, D
    CHANG, CCJ
    CUPP, J
    DEVRIES, JE
    RONCAROLO, MG
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 733 - 733
  • [26] Regulation of B-lymphopoiesis by an adaptor protein, LNK.
    Takaki, S
    Sauer, K
    Iritani, BM
    Chien, S
    Takatsu, K
    Perlmutter, RM
    FASEB JOURNAL, 2000, 14 (06): : A1183 - A1183
  • [27] NEGATIVE REGULATION OF EARLY B-LYMPHOPOIESIS BY INTERLEUKIN-3 AND INTERLEUKIN-1-ALPHA
    HIRAYAMA, F
    CLARK, SC
    OGAWA, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (02) : 469 - 473
  • [28] TCF3 Dominant Negative Variant Causes an Early Block in B-Lymphopoiesis and Agammaglobulinemia
    Ebtehal Al Sheikh
    Peter D. Arkwright
    Archana Herwadkar
    Tracy Hussell
    Tracy A. Briggs
    Journal of Clinical Immunology, 2021, 41 : 1391 - 1394
  • [29] TCF3 Dominant Negative Variant Causes an Early Block in B-Lymphopoiesis and Agammaglobulinemia
    Al Sheikh, Ebtehal
    Arkwright, Peter D.
    Herwadkar, Archana
    Hussell, Tracy
    Briggs, Tracy A.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1391 - 1394
  • [30] CHRONIC LYMPHOCYTIC-LEUKEMIA AND NORMAL B-LYMPHOPOIESIS
    STEVENSON, FK
    SMITH, JL
    IMMUNOLOGY TODAY, 1984, 5 (03): : 60 - 60